U.S. Department of Health and Human Services
Theo Heller
 

 Contact Info

 
Tel: 301-402-7147
Email: theoh@intra.niddk.nih.gov
 

 Select Experience

 
  • Hepatology FellowshipLDB, NIDDK, NIH2003
  • Gastroenterology and Hepatology FellowshipUniversity of Maryland Medical Systems2000
  • Postdoctoral FellowshipHepatitis Viruses Section, NIAID1997
  • Internal Medicine ResidencyGeorgetown University Hospital1993
  • M.D.University of the Witwatersrand1989
  • B.S.University of Cape Town1983
 

 Related Links

 

Theo Heller, M.D.

Investigator, Liver Diseases BranchTranslational Hepatology Unit
Specialties
  • Clinical Research
  • Translational Research

​Research Images

Images or videos appear below. Clicking images or videos provides an expanded view.

TitleDescriptionImage
Gross photograph and magnification of a resected specimen showing NRHGross photograph and magnification of a resected specimen showing NRHEnlarge
Graphic representation of platelet slopes from representative patients in a CGD cohort who died or survived to end of followup in a cohort of CGD patientsThe image depicts platelet slopes from patients in a CGD cohort who (a) died and (b) survived to end of follow-up.  Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease.  Feld JJ, Hussain N, Wright EC, Kleiner DE, Hoofnagle JH, Ahlawat S, Anderson V, Hilligoss D, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T. Gastroenterology. 2008 Jun;134(7):1917-26Graphic representation of platelet slopes from representative patients in a CGD cohort who died or survived to end of followup in a cohort of CGD patientsEnlarge
Graph: Survival function estimate with cohort of CGD patients for each of the determinants of mortality based on the Cox proportional hazards modelEstimate of the survival function in a cohort of CGD patients for each of the determinants of mortality based on the Cox proportional hazards model. The curves compare the survival estimates for patients with and without a) declining platelet slope b) ALP elevations and c) a history of liver abscess. Each curve is adjusted for all factors in the multivariable Cox model. d) This figure compares the survival function for patients with all three determinants of mortality with that for patients with none of these factors. Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. Feld JJ, Hussain N, Wright EC, Kleiner DE, Hoofnagle JH, Ahlawat S, Anderson V, Hilligoss D, Gallin JI, Liang TJ, Malech HL, Holland SM, Heller T. Gastroenterology. 2008 Jun;134(7):1917-26.Graph: Survival function estimate with cohort of CGD patients for each of the determinants of mortality based on the Cox proportional hazards modelEnlarge
Venopathy as a potential cause of nodular regenerative hyperplasiaVenopathy as a potential cause of nodular regenerative hyperplasia. Nodular regenerative hyperplasia: not all nodules are created equal. Reshamwala PA, Kleiner DE, Heller T. Hepatology. 2006 Jul;44(1):7-14 Venopathy as a potential cause of nodular regenerative hyperplasiaEnlarge